• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We're Reading: Clinton Campaign Benefits From Pharma Donations

Article

What we're reading October 19, 2015: Clinton campaign leads rivals in pharma donations, lawmakers in North Carolina open to provider-led organizations and managed care, big surge in Medicare spending on hepatitis C drugs.

Pharma Has Paid Big Money to the Clinton Campaign

Data gathered by the Center for Responsive Politics shows that Hillary Clinton's campaign led the list of 2016 presidential candidates who received donations from the pharmaceutical industry. She received $164,315 in donations from the drug and medical device industries during the first 6 months of the campaign.

Read more here.

NC Lawmakers Compromise on Medicaid Reform, Let ACOs In

North Carolina might soon see the state’s Primary Care Case Management system replaced. Lawmakers in the state have agreed on a compromise that will let managed care organizations and provider-led entities to enter what has traditionally been the realm of commercial health plans. The reforms, yet to be approved by CMS, will not be implemented for several years.

Read more here.

Significant Surge in Medicare Hepatitis C Spending

With about $4.6 billion spent in the first half of 2015 alone—which nearly matches the spend during the entire year in 2014—Medicare spending on hepatitis C drugs is expected to continue its upward trajectory. “We’re all waiting to see when it plateaus or when it possibly goes back down,” said Sean Cavanaugh, director of Medicare and deputy administrator at CMS. “When will that pent-up demand be sated?”

Read more here.

Related Videos
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
dr joseph alvarnas
Screenshot of an interview with A. Mark Fendrick, MD
Screenshot of Scott Soefje, PharmD, BCOP, during  a video interview with. the AJMCtv logo in the top corner
Steve Pickette, PharmD
dr alex jahangir
dr katherine baker
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.